Cannabis and Pain Management

Area of Science:

• Pharmacology
• Evidence-Based Medicine
• Public Health Policy

Background:

• Family physicians are increasingly queried by patients regarding the therapeutic use of cannabis, particularly for pain management.
• Despite widespread state-level legalization and decriminalization, cannabis remains a Schedule 1 drug federally, hindering comprehensive research.
• This legal and regulatory landscape creates a significant gap in evidence-based clinical guidance for physicians.

Purpose of the Study:

• To explore the current understanding of cannabis, including its risks and benefits.
• To provide clinical guidance for family physicians managing patients considering or using cannabis for medical purposes.
• To address the challenges in cannabis research stemming from its federal classification.

Main Methods:

• Literature review of existing studies on cannabis efficacy and safety.
• Analysis of the impact of federal and state laws on cannabis research.
• Synthesis of current evidence to inform clinical practice recommendations.

Main Results:

• Federal prohibition limits research funding and accessibility, resulting in a paucity of high-quality clinical data.
• Existing evidence suggests potential benefits for certain conditions, but risks and side effects must be considered.
• Physicians lack robust guidance, necessitating a cautious approach based on available, albeit limited, evidence.

Conclusions:

• There is a critical need for more research into the clinical utility of cannabis for various medical conditions.
• Physicians must navigate complex legal statuses and limited evidence when advising patients on cannabis use.
• Developing evidence-based recommendations is essential for safe and effective patient care regarding medical cannabis.